Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MatrixMed
AddedFeb 17, 2024
UpdatedJun 18, 2026
MatrixMed

MatrixMed

MatrixMed: Innovating pain relief through propolis-infused pharmaceutical products.

HQ
New York City, NY, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

MatrixMed was founded with the mission to innovate pain relief solutions by leveraging natural and botanical substances. The company's vision is to provide effective and safe alternatives to traditional pain management methods. MatrixMed's flagship product, MTX-14, combines propolis—a natural substance processed by bees known for its anti-microbial properties—with commonly-used analgesic compounds and natural carrier substances. This unique formulation aims to offer enhanced pain relief while minimizing side effects, targeting a market focused on natural and holistic health solutions.

Notable individuals associated with MatrixMed include experts in pharmaceutical development and natural medicine, though specific names are not publicly disclosed. The company has garnered attention from investors interested in the burgeoning field of natural and alternative medicine. Key achievements include the successful development and initial market introduction of MTX-14, which has received positive feedback for its efficacy and safety profile. Overall, MatrixMed is making a significant impact in the pain relief sector by providing innovative, nature-based solutions.

MatrixMed - Similar Companies

Med-X logo

Med-X

medx-rx.com

Moerae Matrix logo

Moerae Matrix

moeraematrix.com

Matrix-Bio logo

Matrix-Bio

Molecular Matrix logo

Molecular Matrix

MedicaMetrix logo

MedicaMetrix

medicametrix.com

MatriSys Bioscience logo

MatriSys Bioscience

matrisysbio.com

Quartet Medicine logo

Quartet Medicine

MedaSystems logo

MedaSystems

medasystems.com

Medinox logo

Medinox

medinox.com

MetasTx logo

MetasTx

metastx.com

MediProPharma logo

MediProPharma

Materna Medical logo

Materna Medical

Intellimedix logo

Intellimedix

Demetrix logo

Demetrix

demetrix.com

NovoThelium logo

NovoThelium

novothelium.com

MatrixMed - Quick Facts

Who are MatrixMed's competitors?

Companies similar to MatrixMed include Med-X, Moerae Matrix, Matrix-Bio and Molecular Matrix.

When was MatrixMed founded?

MatrixMed was founded in 2017.

Where is MatrixMed's headquarters located?

MatrixMed's headquarters is located in New York City, NY, US.

When was MatrixMed's last funding round?

MatrixMed's most recent funding round was for $59k (USD) in January 2018.

How much has MatrixMed raised to-date?

As of Jan 15, 2018, MatrixMed has raised a total of $59k (USD).

How many employees does MatrixMed have?

MatrixMed has 8 employees as of Feb 4, 2024.

MatrixMed - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring Transactional
Main Product
  • Pharmaceuticals
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified